化球微球 通过Nrf2/HO-1通路对抗心血管疾病
Tianwang Guan1,2, Zhenxing Lu2,3, Rundong Tai2,3,4
1Guangdong Engineering Research Center of Boron Neutron Therapy and Application in Malignant Tumors, Dongguan Key Laboratory of Precision Diagnosis and Treatment for Tumors, Dongguan Engineering Research Center for Innovative Boron Drugs and Novel Radioimmune Drugs, Cancer Center, The 10th Affiliated Hospital of Southern Medical University (Dongguan People's Hospital), Southern Medical University, Guangdong, 523059, China.
Bioactive materials
|March 27, 2025
概括
这项研究揭示了化黄素 (Si/Cur) 微球作为与糖尿病和化疗有关的心血管疾病的新疗法. Si/Cur增强了黄素的生物可用性,并防止血管重塑和心脏损伤.
科学领域:
- 生物材料科学 生物材料科学
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病和化疗诱导严重的心血管并发症,如心脏毒性和血管改造.
- 目前对这些疾病的流行病学特征和有效治疗方法的了解有限.
研究的目的:
- 研究与糖尿病和化疗有关的心血管疾病的流行病学特征.
- 开发和评估化素 (Si/Cur) 微球作为心血管疾病的新型治疗剂.
主要方法:
- 从数据库资源中全面分析流行病学数据.
- 化素 (Si/Cur) 微球的设计和合成.
- 研究Si/Cur的作用机制,重点关注Nrf2/HO-1信号通路.
主要成果:
- 化黄素 (Si/Cur) 微球显著提高了黄素的生物可用性.
- Si/Cur有效地抑制了血管重塑,并减轻了心肌损伤.
- 治疗效果通过Nrf2/HO-1信号通路进行介导,扰乱心血管损伤周期.
结论:
- 这项研究为糖尿病和化疗相关的心血管疾病提供了关键的流行病学见解.
- 化黄素 (Si/Cur) 微球是一个有前途的基于生物材料的治疗策略.
- 这些发现为通过准特定的分子通路来管理心血管疾病开辟了新的途径.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


